Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R

MP-AzeFlu is relatively new a pharmaceutical drug used in the treatment of allergic rhinitis. It is comprised of azelastine hydrochloride (AZE), a potent histamine-H1-receptor antagonist and fluticasone propio...

Source: Allergy, Asthma and Clinical Immunology - June 3, 2020 Category: Allergy & Immunology Authors: Sandra Ekstedt, Susanna Kumlien Geor én and Lars Olaf Cardell Tags: Letter to the editor Source Type: research